Non-LVAD-Specific Problems in LVAD Patients

LVAD patients can look deceptively stable during serious non-device emergencies because the pump supports the left ventricle while the right ventricle remains vulnerable. In arrhythmia, shock, GI bleeding, stroke, and sepsis, bedside clues like high-flow or low-flow alarms can change the differential fast.

Arrhythmias and Hemodynamic Collapse

• Well-appearing malignant rhythms: LVAD support can mask dangerous dysrhythmias, so patients with ventricular arrhythmias may look surprisingly well until right-sided failure and pump failure declare themselves.
• Standard rhythm treatment: Treat unstable arrhythmias as you would in any other patient, including cardioversion or defibrillation, while keeping pads off the pump hardware.
• Reversible trigger search: Hyperkalemia and STEMI still matter in LVAD patients with dysrhythmia, because the device does not remove the usual causes of sudden decompensation.
• Perfusion-based arrest decisions: Cardiac arrest assessment hinges on perfusion markers rather than pulse alone, with MAP and end-tidal CO2 helping decide when CPR is truly needed. We walk through that bedside logic in the episode.

Aortic Regurgitation and RV Failure

• High-flow shock physiology: Aortic regurgitation can create a useless recirculation loop where LVAD outflow falls back across the aortic valve, raising displayed flow while systemic perfusion worsens.
• High-flow alarm warning: An ill-appearing LVAD patient with a high-flow alarm should trigger concern for severe aortic regurgitation, not reassurance that cardiac output is adequate.
• Bedside echo clue: Point-of-care echo showing a regurgitant jet through the aortic valve is the key bedside finding when controller numbers do not match the clinical picture.
• Unprotected right ventricle: Right ventricular failure is a major driver of morbidity and mortality after LVAD implantation because the device unloads only the left ventricle.
• Low-flow preload problem: RV failure often presents with a low-flow alarm from reduced preload to the pump, along with shock, congestion, and rising lactate, creatinine, or liver enzymes.

Bleeding, Stroke, and Blood Pressure

• Common GI bleeding site: The GI tract is the most frequent bleeding source in LVAD patients, driven by anticoagulation plus continuous-flow effects like von Willebrand multimer shear and angiodysplasia.
• Early hemostatic moves: Initial management centers on hemodynamic stabilization, blood products as needed, and agents such as high-dose PPI, octreotide, and desmopressin.
• Anticoagulation reversal threshold: Life-threatening hemorrhage may require early reversal with vitamin K and 4-factor PCC, while avoiding large-volume resuscitation that can worsen heart failure. We get into the tradeoffs in the chapter.
• Stroke treatment pivot: Stroke is a major late cause of death after LVAD implantation, and thrombolytics are generally contraindicated, making endovascular therapy the preferred reperfusion path when feasible.
• Afterload sensitivity: Hypertensive emergency matters because LVAD patients are highly sensitive to afterload, but overly aggressive blood pressure reduction can also be harmful.

References:

1. Peberdy MA, Gluck JA, et al; American Heart Association Emergency Cardiovascular Care Committee; Council on Cardiopulmonary, Critical Care, Perioperative, and Resuscitation; Council on Cardiovascular Diseases in the Young; Council on Cardiovascular Surgery and Anesthesia; Council on Cardiovascular and Stroke Nursing; and Council on Clinical Cardiology. Cardiopulmonary Resuscitation in Adults and Children With Mechanical Circulatory Support: A Scientific Statement From the American Heart Association. Circulation. 2017 Jun 13;135(24):e1115-e1134. Epub 2017 May 22. PMID: 28533303.
2. Cho SM, Moazami N, Katz S, Bhimraj A, Shrestha NK, Frontera JA. Stroke Risk Following Infection in Patients with Continuous-Flow Left Ventricular Assist Device. Neurocrit Care. 2019 Aug;31(1):72-80. doi: 10.1007/s12028-018-0662-1. PMID: 30644037.